Navigation Links
Pathology Reports Good for Breast Cancer Studies

Harvard docs say this way of checking estrogen-receptor status of participants is OK

THURSDAY, Feb. 7 (HealthDay News) -- In epidemiological studies of women with breast cancer, pathology reports offer an acceptable alternative to repeated central laboratory testing for determining the estrogen-receptor status of participants, new research suggests.

The use of pathology reports is common practice in such studies, but it wasn't known whether they were accurate, according to the report in a recent issue of the Journal of the National Cancer Institute. Misclassification of estrogen-receptor status could seriously affect study results.

In this study, researchers at Beth Israel Deaconess Medical Center in Boston assessed the reliability of estrogen-receptor results in pathology reports by comparing them to the results of tests performed by a central laboratory.

The results were the same for 1,615 (87.3 percent) of the 1,851 samples checked in the study. This is a high rate of agreement, according to the researchers.

"Our findings, therefore, indicate that using [estrogen-receptor] assay results from pathology reports is a reasonable alternative to using central laboratory testing to obtain [estrogen- receptor] results in large, population-based studies of women with breast cancer," the study authors concluded.

More information

The American Cancer Society has more about breast cancer.

-- Robert Preidt

SOURCE: Journal of the National Cancer Institute news release, Jan. 29, 2008

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Congressman Hoekstra Tours Holland Pathology Laboratory; Learns Vital Role In Patient Care
2. Congressman Davis to Tour Pathology Laboratory, Learn Critical Role in Patient Care
3. Springer founds new electronic journal Head and Neck Pathology
4. Xceed Molecular Launches Ziplex(R) Automated Gene-Expression System at the Association for Molecular Pathology, Booth 84/85
5. Leaders in Pathology Meet in Chicago: Sept. 30 - Oct. 3, 2007
6. American Pacific Reports Revenue Increase of 34% and Net Income of $2.9 Million for Fiscal 2008 First Quarter
7. J.D. Power and Associates Reports: The Nebraska Medical Center Recognized for Providing an Outstanding Inpatient Experience for a Third Consecutive Year, and for Providing an Outstanding Cardiovascular Experience
8. HCA Reports Fourth Quarter - Year End 2007 Results
9. MedCath Corporation Reports First Quarter Earnings
10. DRAXIS Health Reports Fourth Quarter and Year End Results
11. PPD Reports Fourth Quarter and Year-End 2007 Financial Results
Post Your Comments:
Related Image:
Pathology Reports Good for Breast Cancer Studies
(Date:6/27/2016)... Viejo, California (PRWEB) , ... June 27, 2016 , ... ... are fully customizable inside of Final Cut Pro X," said Christina Austin - CEO ... another unique style. Final Cut Pro X users can now reveal the ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... its strategic partnership with Connance, a healthcare industry leader providing predictive analytics ... proprietary technology combine to provide health systems, hospitals and ambulatory surgical centers ...
(Date:6/27/2016)... , ... June 27, 2016 , ... recently awarded ... Eyeglasses . , Millions of individuals in the United States and Canada wear ... a way to both correct vision and make a fashion statement. Even celebrities use ...
(Date:6/26/2016)... Battle Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... abuse, joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table ... held in honor of the city’s history as home to some of the world’s ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned ... developed to enhance the health of felines. The formula is all-natural and is made ... in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... WAYNE, Pa. , June 23, 2016 ... provider, will launch its next generation clinical outcomes platform, Bracket ... DIA Meeting held on June 26 – 30, 2016 in ... 6.0, the first electronic Clinical Outcome Assessment product of its ... DIA Booth #715. Bracket eCOA 6.0 is a ...
Breaking Medicine Technology: